Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2025-12-25 @ 3:22 AM
NCT ID:
NCT01074905
Eligibility Criteria:
Inclusion Criteria:
* Adults and children \> 6 months
* Weight \> 7 kg for children
* Have not had primaquine since last Pv episode
* Participant (or parent/guardian if \< 18 years old) is willing and able to give written informed consent
* Microscopic diagnosis of Plasmodium vivax mono-infection
* Ability (in the investigators opinion) and willingness of patient or parent/guardian to comply with all study requirements
Exclusion Criteria
* Allergy to artesunate, chloroquine or primaquine
* Severe malaria
* Patients with microscopic diagnosis of co-infection with Plasmodium falciparum
* Presence of any condition which in the judgement of the investigator would place the subject at undue risk or interfere with the results of the study
* Inability to tolerate oral medication
* Pregnancy
* Blood transfusion in the last 3 months
* Antimalarial in last 2 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Months
Study:
NCT01074905
Study Brief:
Protocol Section:
NCT01074905